You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

CLINICAL TRIALS PROFILE FOR METYROSINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for METYROSINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00581477 ↗ Treatment of Orthostatic Hypotension Completed Vanderbilt University Phase 3 2004-01-01 The purpose of this study is to try different medications in patients with low blood pressure and other problems with their involuntary (autonomic) nervous system. The pharmacological trials in this study will perhaps lead to more effective treatment. This study consists of single dose trials, dose selection trials, 5-day trials and chronic (approximately 2 months) trials.
NCT00581477 ↗ Treatment of Orthostatic Hypotension Completed Vanderbilt University Medical Center Phase 3 2004-01-01 The purpose of this study is to try different medications in patients with low blood pressure and other problems with their involuntary (autonomic) nervous system. The pharmacological trials in this study will perhaps lead to more effective treatment. This study consists of single dose trials, dose selection trials, 5-day trials and chronic (approximately 2 months) trials.
NCT01127503 ↗ Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Terminated Bausch Health Americas, Inc. Phase 2 2010-06-01 This is an exploratory clinical investigation. The objectives of this study are to evaluate the safety, steady-state pharmacokinetics, and efficacy of metyrosine (Demser®) for the treatment of psychosis in patients with velocardiofacial syndrome (VCFS).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for METYROSINE

Condition Name

Condition Name for METYROSINE
Intervention Trials
Autonomic Nervous System Diseases 1
Dopamine Beta-Hydroxylase Deficiency 1
Orthostatic Hypotension 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for METYROSINE
Intervention Trials
Pancreatic Neoplasms 1
Orthostatic Intolerance 1
Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for METYROSINE

Trials by Country

Trials by Country for METYROSINE
Location Trials
United States 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for METYROSINE
Location Trials
California 2
New York 2
Alabama 1
Arizona 1
Arkansas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for METYROSINE

Clinical Trial Phase

Clinical Trial Phase for METYROSINE
Clinical Trial Phase Trials
Phase 3 1
Phase 2/Phase 3 1
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for METYROSINE
Clinical Trial Phase Trials
Active, not recruiting 1
Completed 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METYROSINE

Sponsor Name

Sponsor Name for METYROSINE
Sponsor Trials
Tyme, Inc 2
Valeant Pharmaceuticals International, Inc. 1
Joseph Ahmed Foundation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for METYROSINE
Sponsor Trials
Other 4
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.